MEDIROM Healthcare Technologies Inc. (MRM) is a Personal Products & Services company in the Consumer Cyclical sector, currently trading at $1.26. It has a SharesGrow Score of 62/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of MRM = $8.55 (+578.6% from the current price, the stock appears undervalued).
Valuation: MRM trades at a trailing Price-to-Earnings (P/E) of 0 (S&P 500 average ~25).
Financials: revenue is $8.3B, +16.1%/yr average growth. Net income is $149M, growing at +40.5%/yr. Net profit margin is 1.8% (thin). Gross margin is 27.1% (+0.9 pp trend).
Balance sheet: total debt is $4.0B against $933M equity (Debt-to-Equity (D/E) ratio 4.24, leveraged). Current ratio is 0.65 (tight liquidity). Debt-to-assets is 48.9%. Total assets: $8.1B.
Analyst outlook: 1 / 1 analysts rate MRM as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 90/100 (Pass), Past 75/100 (Partial), Health 0/100 (Fail), Moat 37/100 (Fail), Future 100/100 (Pass), Income 30/100 (Fail).
